Publication | Closed Access

Second-line Chemotherapy with the Association of Liposomal Daunorubicin, Carboplatin and Etoposide in Children with Recurrent Malignant Brain Tumors

Neuro-oncologyPediatric Brain TumorsMedicinePharmacologyPathologyAnti-cancer AgentLiposomal DaunorubicinCancer TreatmentOncologyMalignant DiseaseCancer ResearchSecond-line Chemotherapy